Learn the latest research on CYP inhibition – how to improve in vivo relevance of in vitro studies by conducting the incubations with human hepatocytes instead of liver microsomes.
Admescope’s scientist continuously innovate and conduct research to advance the field of ADME-Tox. Our scientist have published more than hundred peer-reviewed scientific articles over the years.
We are delighted to be able to present the results of our latest research to you.
Date: 17th May 2017
Time: 08:30 – 12:00
Venue: Residence of the Ambassador, Embassy of Finland, Grønningen 11, 1270 København K.
To whom: Pharmaceutical professionals interested in drug discovery and development projects
Program:
| 08:30 – 09:00 | Registration and coffee |
| 09:00 – 09:20 | Opening words Ambassador of Finland Ann-Marie Nyroos |
| 09:20 – 09:35 | Admescope company introduction Dr Ari Tolonen, CEO |
| 09:35 – 10:30 | Scientific Presentation: CYP inhibition with human hepatocytes Dr Aki Heikkinen, Senior Scientist |
| 10:30 – 10:45 | Questions and Answers |
| 10:45 – 12:00 | Brunch |
Speakers:
 |
Dr Ari Tolonen, CEO Dr. Ari Tolonen has more than a decade of experience as a head of ADME CRO |
 |
Dr Aki Heikkinen, Senior Scientist Dr. Aki Heikkinen has worked in the pharma industry in Switzerland as a Roche Postdoc |
In collaboration with:
